Clinical trial
Effect of Anti-IgE in Chronic Urticaria
NCT00130234 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00130234 |
|---|---|
| Title | Effect of Anti-IgE in Chronic Urticaria |
| Official title | Effect of Anti-IgE in Chronic Urticaria |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urticaria |
| Intervention type | Drug |
| Interventions | Xolair® (Omalizumab) |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Aug 15, 2005 |
| Last update posted | May 7, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: